StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the stock.
Separately, HC Wainwright reiterated a buy rating and issued a $3.50 target price on shares of SenesTech in a research note on Tuesday, May 14th.
Read Our Latest Report on SenesTech
SenesTech Stock Down 0.9 %
SenesTech (NASDAQ:SNES – Get Free Report) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). The business had revenue of $0.42 million for the quarter, compared to analysts’ expectations of $0.43 million. SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. During the same quarter in the previous year, the company posted ($15.85) earnings per share. As a group, research analysts expect that SenesTech will post -1.1 earnings per share for the current fiscal year.
Institutional Trading of SenesTech
A hedge fund recently bought a new stake in SenesTech stock. Armistice Capital LLC bought a new position in SenesTech, Inc. (NASDAQ:SNES – Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned approximately 1.94% of SenesTech at the end of the most recent reporting period. Institutional investors own 5.19% of the company’s stock.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- Conference Calls and Individual Investors
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- How to Invest in the FAANG Stocks
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Investing in large cap stocks: Diving into big caps
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.